The aim of the study is to evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms. Results and postoperative events are reported in accordance with the current reporting standards for endovascular aortic repair prepared and revised by the Ad Hoc Committee for Standardized Reporting Practices in Vascular Surgery of The Society for Vascular Surgery/American Association for Vascular Surgery. The Registry will include approximately 300 patients treated from January 2015 to May 2021 (retrospective arm) and June 2021 to June 2023 (perspective arm) for the routine treatment of para-renal and thoraco-abdominal aneurysms. To reach 300 patients, the enrollments can be extended until June 2026.
Study Type
OBSERVATIONAL
Enrollment
741
Evaluate the outcomes of the preloaded stent-graft design (PLD) in the routine treatment of para-renal and thoraco-abdominal aneurysms
Massachusetts General Hospital
Boston, Massachusetts, United States
UMass Memorial Center for Complex Aortic Disease
Worcester, Massachusetts, United States
Southwestern Medical Center, Dallas
Dallas, Texas, United States
McGovern Medical School
Houston, Texas, United States
University of Washington Seatle
Seattle, Washington, United States
Copenhagen Aortic Center
Copenhagen, Denmark
Centre Hospitalier Universitaire
Lille, France
Timone Hospital Marseille
Marseille, France
Centre Hospitalier Universitaire de Nantes
Nantes, France
Aortic Centre Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris Saclay
Paris, France
...and 9 more locations
Clinical success
absence of death, type I/III endoleak, graft infection/thrombosis, aneurysm expansion and/or rupture, conversion to open repair, or new treatment-related thoraco-abdominal pathologies
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.